HB新闻

我们知道我们的东西。

久经考验的专业知识无可替代。这就是为什么全球领先的媒体经常向 Harris Sliwoski 寻求我们的见解。

新闻中的HB

Griffen Thorne in Willamette Week

Looking to make money in psychedelics? Look elsewhere.

That’s the message from lawyer Griffen Thorne at Harris Sliwoski Sliwoski LLP, a Portland firm that specializes in the legal cannabis industry and, more recently, psychedelics.

“Anyone familiar with the cannabis industry knows how difficult it is to make money,” Thorne wrote on the firm’s site today. “Things are going to be even worse for people in the state-legal psychedelics industry—much worse.”

Thorne cites a half-dozen hurdles for anyone trying to make a living with psilocybin: competition from physicians if psilocybin wins Food and Drug Administration approval (it’s in Phase 3 trials); opposition from pharmaceutical companies that are working to get those approvals; high costs for running a psilocybin service center; black-market competition; and growing religious use of psilocybin.

Robert Kossick in Bloomberg Law

“US businesses—big and small alike—whose operational viability requires economic engagement in China must recognize how the worlds of law, policy, practice, and technology have converged, and they must adapt accordingly. This means developing and implementing a customized strategy that can be used to navigate the challenging due diligence requirements of the Uyghur Forced Labor Prevention Act.”

Vince Sliwoski and Adams Lee in Law360

Recently, a pair of large cannabis companies, MMJ International
Holdings Corp. and Global Cannabis Holdings, made waves by
announcing they had formed a partnership to import cannabis THC
products into the U.S.

The announcement did not identify the type of THC cannabis
products slated for import, or the legal strategy the companies would
pursue. However, many cannabis operators seem to be wondering
whether it is legal to import THC products — and specifically cannabis
seeds — into the U.S.